Catabasis shares the latest edition of their community newsletter, including information about the role of NF-kB in muscle and an update about edasalonexent in development for the treatment of Duchenne.
November 13, 2019 / Clinical Trials
Catabasis shares the latest edition of their community newsletter, including information about the role of NF-kB in muscle and an update about edasalonexent in development for the treatment of Duchenne.